Advertisement

Health


LuminaX Healthtech Accelerator accepts record cohort of founders for 2024

LuminaX Healthtech Accelerator accepts record cohort of founders for 2024

The Gold Coast’s LuminaX HealthTech Accelerator has accepted ...

Zea Relief gets a healthy boost to its retail footprint through Woolworths distribution deal

Zea Relief gets a healthy boost to its retail footprint through Woolworths distribution deal

Zea Relief, a Tasmanian wellness scale-up that has developed a rang...

AI medtech Artrya secures first Australian commercial agreement with The Cardiac Centre NSW

AI medtech Artrya secures first Australian commercial agreement with The Cardiac Centre NSW

Perth-based medtech Artrya (ASX: AYA) has secured the first commerc...

Australia’s biggest chemist is merging with a giant wholesaler. Could we soon be paying more?

Australia’s biggest chemist is merging with a giant wholesaler. Could we soon be paying more?

Corporate Australia loves a big merger. And amid a growing flurry o...

Genesis Capital lifts Pacific Smiles takeover bid to $279 million

Genesis Capital lifts Pacific Smiles takeover bid to $279 million

Pacific Smiles (ASX: PSQ) suitor Genesis Capital has brus...

Advertisement
Advertisement
Advertisement
Record flu vaccine demand gives 44 per cent shot in the arm to CSL earnings

Record flu vaccine demand gives 44 per cent shot in the arm to CSL earnings

Mitigation measures against COVID-19 led to a drastic reduction i...

Profits double for IVF specialist Virtus Health

Profits double for IVF specialist Virtus Health

As the leading assisted reproductive services (ARS) company ...

Noxopharm study results herald "new era" for prostate cancer treatment

Noxopharm study results herald "new era" for prostate cancer treatment

A trial of Noxopharm's (ASX: NOX) prostate cancer treatment h...

What's the difference between mutations, variants and strains? A guide to COVID terminology

What's the difference between mutations, variants and strains? A guide to COVID terminology

Living through a global pandemic over the past year has seen all ...

Mesoblast rises on positive back pain trial results

Mesoblast rises on positive back pain trial results

Positive results from stem cell research company Mesoblast's ...

Eyes and ears on Healthia as shares double in four months

Eyes and ears on Healthia as shares double in four months

Investors appeared to take little notice of allied health group H...

Little Green Pharma plans $22m raise to boost cannabis production and push internationally

Little Green Pharma plans $22m raise to boost cannabis production and push internationally

Medicinal cannabis cultivator and manufacturer Little Green Phar...

Why Cynata is hopeful its COVID treatment trial will succeed where others have failed

Why Cynata is hopeful its COVID treatment trial will succeed where others have failed

Cynata Therapeutics (ASX: CYP), founded by two clever stem cell r...

How Smiles Inclusive was turned upside down: A timeline of decay

How Smiles Inclusive was turned upside down: A timeline of decay

For retail investors there is something very reassuring about putti...

AnteoTech spikes on customer Ellume's $304m US contract news

AnteoTech spikes on customer Ellume's $304m US contract news

Shares in Brisbane-based nanotechnology company AnteoTech (ASX: A...

Ellume secures $304m US Government contract to scale up COVID-19 test production

Ellume secures $304m US Government contract to scale up COVID-19 test production

Brisbane-based diagnostics company Ellume has today announced a U...

Tomas Steenackers mimics National Vet Care with new optometry venture

Tomas Steenackers mimics National Vet Care with new optometry venture

After the ASX-listed company he founded was offered a $251.5 mill...

Little Green Pharma finds French foothold as primary manufacturer for cannabis trial

Little Green Pharma finds French foothold as primary manufacturer for cannabis trial

Medicinal cannabis company Little Green Pharma (ASX: LGP) is toda...

Immutep's EAT COVID trial progresses to the next phase

Immutep's EAT COVID trial progresses to the next phase

A trial of biotechnology company Immutep's (ASX: IMM) experim...

AnteoTech's rapid-test success shines light on Brisbane as a COVID tech hub

AnteoTech's rapid-test success shines light on Brisbane as a COVID tech hub

AnteoTech's (ASX: ADO) plans to bring a rapid COVID-19 test t...

Advertisement

Partner Content

In today's fast-paced investment landscape, time is a valuable commo...
Private credit specialist Finexia Financial Group (ASX: FNX) has se...
After relocating his Canberra-founded company Whitefox Recruitment ...
Armed with a growing business and a great opportunity, a business o...
The digital revolution may have changed the office forever, but the...
Private credit specialist Finexia Financial Group (ASX: FNX) has ac...
Environmental engineer Romin Nejad began his career at Epic Environ...
The transition from elite athlete and gymnastics coach to a corpora...
Advertisement